170 related articles for article (PubMed ID: 38370349)
1. U-Shaped relationship of insulin-like growth factor I and incidence of nonalcoholic fatty liver in patients with pituitary neuroendocrine tumors: a cohort study.
Hu Y; Yuan C; Abdulnaimu M; Memetmin J; Jie Z; Tuhuti A; Abudueini H; Guo Y
Front Endocrinol (Lausanne); 2024; 15():1290007. PubMed ID: 38370349
[TBL] [Abstract][Full Text] [Related]
2. Relationship between growth hormone deficiency and nonalcoholic fatty liver disease in patients with pituitary stalk interruption syndrome.
Huang Q; Xu H; Wang X; Mao J; Yu B; Zhu Y; Zhang R; Sun B; Zhang J; Ji W; Ma W; Nie M; Wu X
Clin Endocrinol (Oxf); 2022 Nov; 97(5):612-621. PubMed ID: 35384023
[TBL] [Abstract][Full Text] [Related]
3. The Relationship between the Growth Hormone/Insulin-like Growth Factor System and the Histological Features of Nonalcoholic Fatty Liver Disease.
Chishima S; Kogiso T; Matsushita N; Hashimoto E; Tokushige K
Intern Med; 2017; 56(5):473-480. PubMed ID: 28250290
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor 1 and metabolic parameters are associated with nonalcoholic fatty liver disease in obese children and adolescents.
Liang S; Cheng X; Hu Y; Song R; Li G
Acta Paediatr; 2017 Feb; 106(2):298-303. PubMed ID: 27889912
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-1 and non-alcoholic fatty liver disease: a systemic review and meta-analysis.
Yao Y; Miao X; Zhu D; Li D; Zhang Y; Song C; Liu K
Endocrine; 2019 Aug; 65(2):227-237. PubMed ID: 31243652
[TBL] [Abstract][Full Text] [Related]
6. Circulating IGFBP-2 levels are inversely associated with the incidence of nonalcoholic fatty liver disease: A cohort study.
Yang J; Zhou W; Wu Y; Xu L; Wang Y; Xu Z; Yang Y
J Int Med Res; 2020 Aug; 48(8):300060520935219. PubMed ID: 32762395
[TBL] [Abstract][Full Text] [Related]
7. Relationship of IGF-1 and IGF-Binding Proteins to Disease Severity and Glycemia in Nonalcoholic Fatty Liver Disease.
Stanley TL; Fourman LT; Zheng I; McClure CM; Feldpausch MN; Torriani M; Corey KE; Chung RT; Lee H; Kleiner DE; Hadigan CM; Grinspoon SK
J Clin Endocrinol Metab; 2021 Jan; 106(2):e520-e533. PubMed ID: 33125080
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-190b regulates lipid metabolism and insulin sensitivity by targeting IGF-1 and ADAMTS9 in non-alcoholic fatty liver disease.
Xu M; Zheng XM; Jiang F; Qiu WQ
J Cell Biochem; 2018 Jul; 119(7):5864-5874. PubMed ID: 29575055
[TBL] [Abstract][Full Text] [Related]
9. Dose-Response Associations of Metabolic Score for Insulin Resistance Index with Nonalcoholic Fatty Liver Disease among a Nonobese Chinese Population: Retrospective Evidence from a Population-Based Cohort Study.
Cai X; Gao J; Hu J; Wen W; Zhu Q; Wang M; Liu S; Hong J; Wu T; Yang S; Tuerxun G; Li N
Dis Markers; 2022; 2022():4930355. PubMed ID: 35251371
[TBL] [Abstract][Full Text] [Related]
10. Association between triglyceride glucose-body mass index and non-alcoholic fatty liver disease in the non-obese Chinese population with normal blood lipid levels: a secondary analysis based on a prospective cohort study.
Li Y; Zheng R; Li J; Feng S; Wang L; Huang Z
Lipids Health Dis; 2020 Oct; 19(1):229. PubMed ID: 33109219
[TBL] [Abstract][Full Text] [Related]
11. Expression of IGF-1 receptor and GH receptor in hepatic tissue of patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Osganian SA; Subudhi S; Masia R; Drescher HK; Bartsch LM; Chicote ML; Chung RT; Gee DW; Witkowski ER; Bredella MA; Lauer GM; Corey KE; Dichtel LE
Growth Horm IGF Res; 2022 Aug; 65():101482. PubMed ID: 35780715
[TBL] [Abstract][Full Text] [Related]
12. High Prevalence of Nonalcoholic Fatty Liver Disease Among Adolescents and Young Adults With Hypopituitarism due to Growth Hormone Deficiency.
Kang SJ; Kwon A; Jung MK; Chae HW; Kim S; Koh H; Shin HJ; Kim HS
Endocr Pract; 2021 Nov; 27(11):1149-1155. PubMed ID: 34126247
[TBL] [Abstract][Full Text] [Related]
13. Relationship between serum circulating insulin-like growth factor-1 and liver fat in the United States.
Runchey SS; Boyko EJ; Ioannou GN; Utzschneider KM
J Gastroenterol Hepatol; 2014 Mar; 29(3):589-96. PubMed ID: 24716226
[TBL] [Abstract][Full Text] [Related]
14. U-shaped association between triglyceride and risk of incident diabetes in normoglycemic males with NAFLD: A population-base cohort study.
Xie X; Liao J; Huang C; Li X; Cao Q; Kong L; Okamura T; Hashimoto Y; Obora A; Kojima T; Fukui M; Hamaguchi M; Luo Z; Qin Y; Liang X; Xuan X
Int J Med Sci; 2023; 20(11):1417-1424. PubMed ID: 37790852
[No Abstract] [Full Text] [Related]
15. Nonalcoholic fatty liver disease is associated with low circulating levels of insulin-like growth factor-I.
Arturi F; Succurro E; Procopio C; Pedace E; Mannino GC; Lugarà M; Procopio T; Andreozzi F; Sciacqua A; Hribal ML; Perticone F; Sesti G
J Clin Endocrinol Metab; 2011 Oct; 96(10):E1640-4. PubMed ID: 21816784
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-I, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease.
Hribal ML; Procopio T; Petta S; Sciacqua A; Grimaudo S; Pipitone RM; Perticone F; Sesti G
J Clin Endocrinol Metab; 2013 Feb; 98(2):E304-8. PubMed ID: 23316084
[TBL] [Abstract][Full Text] [Related]
17. Association between the lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes in a healthy population of Northwest China: a retrospective cohort study with a 2-year follow-up period.
Li N; Xang W; Wu S; Li D; Chang M; Xie C; Zhang MY; Tan H
Front Endocrinol (Lausanne); 2023; 14():1173757. PubMed ID: 37435491
[TBL] [Abstract][Full Text] [Related]
18. Red meat consumption, obesity, and the risk of nonalcoholic fatty liver disease among women: Evidence from mediation analysis.
Kim MN; Lo CH; Corey KE; Luo X; Long L; Zhang X; Chan AT; Simon TG
Clin Nutr; 2022 Feb; 41(2):356-364. PubMed ID: 34999330
[TBL] [Abstract][Full Text] [Related]
19. New onset non-alcoholic fatty liver disease after resection of pancreatic neuroendocrine tumors.
Mackay TM; Genç CG; Takkenberg RB; Besselink MG; Somers I; Nieveen van Dijkum EJM
J Surg Oncol; 2018 Jun; 117(7):1548-1555. PubMed ID: 29572825
[TBL] [Abstract][Full Text] [Related]
20. Ghrelin-insulin-like growth factor-1 axis is activated via autonomic neural circuits in the non-alcoholic fatty liver disease.
Nagoya T; Kamimura K; Inoue R; Ko M; Owaki T; Niwa Y; Sakai N; Setsu T; Sakamaki A; Yokoo T; Kamimura H; Nakamura Y; Ueno M; Terai S
Neurogastroenterol Motil; 2020 May; 32(5):e13799. PubMed ID: 31984635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
